Qualigen Therapeutics effects 1-for-50 reverse stock split to regain Nasdaq compliance

AIxCrypto Holdings, Inc.

Reverse stock split at 1:50 ratio effective 12:01 a.m. ET on November 5, 2024.
Reduces outstanding shares from ~36.8M to approx. 736k shares; no change in authorized shares.
No fractional shares; cash in lieu paid at $5.055 per pre-split share (closing price on Nov 4).
Intended to meet Nasdaq $1.00 minimum bid price requirement (Rule 5550(a)(2)).
Trading symbol remains QLGN; CUSIP changed to 74754R 301.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.